URGN (urogen.com) Earnings per share growth rate in current year

URGN (UroGen Pharma Corp) - company brandmark

UroGen Pharma Ltd. (URGN) operates in a highly competitive environment against industry behemoths offering comprehensive treatment methods. However, experienced management under Liz Barrett is successfully commercializing its developments. Efficient logistics for targeted drugs ensure high margins, as evidenced by the annual earnings per share growth rate, where the current level is 88.50.

UroGen Pharma Ltd (URGN) Earnings per share growth in current year: for the period 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for urogen.com (URGN)

- stock price and consensus target price:
Fundamental valuation:URGN UroGen Pharma Corp
Signature product of UroGen Pharma Ltd.

The scaling of Jelmyto sales and the implementation of UGN-102 directly drive the year-over-year earnings per share trend for UroGen Pharma Ltd. (URGN), which currently stands at 88.50. This indicator measures the percentage shift in EPS relative to the previous year, allowing investors to assess the pace of capitalization of the company's market monopoly and identify risks of marginal pressure on the business's operational efficiency.

Main competitors

Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings growth in current year BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth rate in current year|Erasca Oncology - Earnings growth in current year|DCTH: Earnings per share growth in current year|YMAB: Earnings growth in current year|Aura Bio (AURA) - Earnings growth in current year|CADL (Candel Therapeutics Inc.) - Earnings growth in current year|ARAY: Earnings per share increase in current year|Net earnings per share growth this year SLS (SELLAS Life Sciences Group, Inc.)|Net earnings per one share growth for the current year ACTU|Citius Oncology - Net earnings per share growth this year|Earnings per share increase in current year HURA|TARA: Net earnings per share growth this year|Earnings per share growth rate in current year Fate Pharma|Aadi Bioscience Inc (WHWK) - Earnings per share growth in current year|Earnings per share growth rate in current year TScan (TCRX)|Net earnings per share growth this year CSBR|xbiotech.com (XBIT) - Expected net earnings per share growth this year|Earnings per share growth in current year cel-sci.com (CVM)|OSTX - Earnings per share growth rate in current year|Radiopharm Theranostics - Net earnings per share growth this year|Earnings per share increase in current year ARTV|ANL - Earnings per share growth in current year|VERU - Earnings growth in current year|Tempest Therapeutics, Inc. (TPST) - Earnings per share growth in current year|XLO: Net earnings per one share growth for the current year|RENB (Renovaro Biosciences) - Earnings growth in current year|MURA: Earnings per share increase in current year|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|Net earnings per one share growth for the current year OKUR|CytoMed Therapeutics Limited - Net earnings per share growth this year|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma